View Latest Medical and Pharma Bids and Tenders

Plan For Selecting Contractors For The Package Of Providing Hiv/Aids Treatment Drugs On The List Of Drugs Subject To Price Negotiation Under Health Insurance In 2024 - 2025 (Phase 2) Implemented By The National Drug Centralized Procurement Center

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bosutinib, Atc L01Ea04 (Obg) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Exclusively Timothy Grass Pollen (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Bimekizumab, Atc L04Ac21 (Obo) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Allergen Extract From Timothy Grass, Sweetgrass, Etc. (Excl. Sut), Atc V01Aa02 For The Period 01.10.24-30.09.26

Additional Purchase Of Health Insurance Drugs In 2024 (First Time)

Blood Component Fractionation Device Insurance

Testing Of Medical Devices And Laboratory Equipment According To Dguv V3

Announcement On The Correction Of The Employee Commercial Supplementary Medical Insurance Project For 2024-2025 Of The Guizhou Branch Of The Air Traffic Management Bureau Of The Southwest Region Of The Civil Aviation Administration Of China